Form D · Pharmaceuticals

WELLESLEY PHARMACEUTICALS LLC

Newtown, PA · CIK 0001634861

Offering snapshot reported Oct 13, 2017 · SEC filing

Reported sold
$3.78M
Offering amount: $5.78M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 28, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.89M$3.78MApr 20, 2016: $298,377.00Apr 20, 2016Feb 3, 2017: $348,376.00Feb 3, 2017Oct 13, 2017: $3,777,581.00Oct 13, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$348,376 → $3,777,581
  • Reported investors9 → 14

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2017Amendment$3,777,581$3,429,205vs Feb 3, 201714SEC filing
Feb 3, 2017Amendment$348,376$49,999vs Apr 20, 20169SEC filing
Apr 20, 2016Initial$298,377No comparison8SEC filing
Feb 27, 2015Initial$934,902No comparison18SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$150K (estimated)
Finders' fees
$0
Form D file number
021-261698
The sales commission will be 6% to 7.5% of the cash the individual raises.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Dale BenzineNoneHealthcare Capital and Mergers

Source: Form D, filed Oct 13, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Alan Dill Director, Executive
Candan Karabagli Director
Omer Karahan Director
Christopher Lineberry Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3 Valley View Drive
Newtown, PA, 18940